Home  >  Products  >  CLK1 (CDC-like kinase 1) Blocking Peptide (the N terminal of CLK1)(100ug)
CLK1 (CDC-like kinase 1) Blocking Peptide (the N terminal of CLK1)(100ug)

CLK1 (CDC-like kinase 1) Blocking Peptide (the N terminal of CLK1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CLK1 Antibody(ARP52021_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP52021
Size: 100ug
Weight: 57kDa
Gene: 1195
Format: Lyophilized powder
Target: This gene encodes a member of the CDC2-like (or LAMMER) family of dual specificity protein kinases. In the nucleus, the encoded protein phosphorylates serine/arginine-rich proteins involved in pre-mRNA processing, releasing them into the nucleoplasm. The choice of splice sites during pre-mRNA processing may be regulated by the concentration of transacting factors, including serine/arginine rich proteins. Therefore, the encoded protein may play an indirect role in governing splice site selection. Multiple transcript variants encoding different isoforms have been found for this gene.
Alternative names: CLK; CLK/STY; STY
See Full Product Listings >